Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity

International Journal of Environmental Research and Public Health

Volumn 8, Issue 7, 2011, Pages 2980-3018

  Kraft, Andrew D ^a   Jean Harry, G ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cytokines; Environmental exposure; Microglia; Neurodegeneration; Neuroinflammation; Neurotoxicity

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SYNUCLEIN; CD11B ANTIGEN; CD200 RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANGANESE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PRION PROTEIN; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

AIR POLLUTION; BONE MARROW CELL; CATALYSIS; CELL EXPANSION; CELL LINEAGE; CELL LOSS; CELL MIGRATION; CELL RENEWAL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; EXCITOTOXICITY; EXHAUST GAS; HUMAN; IMMUNOREACTIVITY; INNATE IMMUNITY; LONG TERM POTENTIATION; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; T LYMPHOCYTE; UPREGULATION;

EID: 79960784323     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8072980     Document Type: Review

References (281)

1. Streit, W.J. Microglial senescence: Does the brain's immune system have an expiration date? Trends Neurosci. 2006, 29, 506-510.
2. Streit, W.J.; Sammons, N.W.; Kuhns, A.J.; Sparks, D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45, 208-212.
3. Raivich, G. Like cops on the beat: The active role of resting microglia. Trends Neurosci. 2005, 28, 571-573.
4. Galea, I.; Bechmann, I.; Perry, V.H. What is immune privilege (not)? Trends Immunol. 2007, 28, 12-18.
5. Ginhoux, F.; Greter, M.; Leboeuf, M.; Nandi, S.; See, P.; Gokhan, S.; Mehler, M.F.; Conway, S.J.; Ng, L.G.; Stanley, E.R., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330, 841-845.
6. McMahon, E.J.; Bailey, S.L.; Castenada, C.V.; Waldner, H.; Miller, S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11, 335-339.
7. Cannella, B.; Raine, C.S. Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 2004, 55, 46-57.
8. Fassbender, K.; Mielke, O.; Bertsch, T.; Muehlhauser, F.; Hennerici, M.; Kurimoto, M.; Rossol, S. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 1999, 53, 1104-1106.
9. Jander, S.; Stoll, G. Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 2001, 114, 253-258.
10. Shi, F.D.; Takeda, K.; Akira, S.; Sarvetnick, N.; Ljunggren, H.G. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 2000, 165, 3099-3104.
11. Chang, T.T.; Sobel, R.A.; Wei, T.; Ransohoff, R.M.; Kuchroo, V.K.; Sharpe, A.H. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice. Eur. J. Immunol. 2003, 33, 2022-2032.
12. Bailey, S.L.; Carpentier, P.A.; McMahon, E.J.; Begolka, W.S.; Miller, S.D. Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 2006, 26, 149-188.
13. Bartholomaus, I.; Kawakami, N.; Odoardi, F.; Schlager, C.; Miljkovic, D.; Ellwart, J.W.; Klinkert, W.E.; Flugel-Koch, C.; Issekutz, T.B.; Wekerle, H.; Flugel, A. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462, 94-98.
14. Becher, B.; Bechmann, I.; Greter, M. Antigen presentation in autoimmunity and CNS inflammation: How T lymphocytes recognize the brain. J. Mol. Med. 2006, 84, 532-543.
15. Hickey, W.F.; Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239, 290-292.
16. Kivisakk, P.; Imitola, J.; Rasmussen, S.; Elyaman, W.; Zhu, B.; Ransohoff, R.M.; Khoury, S.J. Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 2009, 65, 457-469.
17. McMahon, E.J.; Bailey, S.L.; Miller, S.D. CNS dendritic cells: Critical participants in CNS inflammation? Neurochem. Int. 2006, 49, 195-203.
18. Kawakami, N.; Lassmann, S.; Li, Z.; Odoardi, F.; Ritter, T.; Ziemssen, T.; Klinkert, W.E.; Ellwart, J.W.; Bradl, M.; Krivacic, K., et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 2004, 199, 185-197.
19. Ni, M.; Li, X.; Yin, Z.; Sidoryk-Wegrzynowicz, M.; Jiang, H.; Farina, M.; Rocha, J.B.; Syversen, T.; Aschner, M. Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia 2011, 59, 810-820.
20. Hutchinson, M.R.; Loram, L.C.; Zhang, Y.; Shridhar, M.; Rezvani, N.; Berkelhammer, D.; Phipps, S.; Foster, P.S.; Landgraf, K.; Falke, J.J.; Rice, K.C.; Maier, S.F.; Yin, H.; Watkins, L.R. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience 2010, 168, 551-563.
21. Wang, Y.; Wang, B.; Zhu, M.T.; Li, M.; Wang, H.J.; Wang, M.; Ouyang, H.; Chai, Z.F.; Feng, W.Y.; Zhao, Y.L. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol. Lett. 2011, 205, 26-37.
22. Dutta, K.; Ghosh, D.; Nazmi, A.; Kumawat, K.L.; Basu, A. A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. PLoS One 2010, 5, e9984:1-e9984:14.
23. Napoli, I.; Neumann, H. Microglial clearance function in health and disease. Neuroscience 2009, 158, 1030-1038.
24. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J.V.; Zuo, Y.; Jung, S.; Littman, D.R.; Dustin, M.L.; Gan, W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8, 752-758.
25. Kreutzberg, G.W. Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 1996, 19, 312-318.
26. Kimoto, H.; Eto, R.; Abe, M.; Kato, H.; Araki, T. Alterations of glial cells in the mouse hippocampus during postnatal development. Cell Mol. Neurobiol. 2009, 29, 1181-1189.
27. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308, 1314-1318.
28. Biber, K.; Neumann, H.; Inoue, K.; Boddeke, H.W. Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci. 2007, 30, 596-602.
29. Neumann, H. Control of glial immune function by neurons. Glia 2001, 36, 191-199.
30. Pocock, J.M.; Kettenmann, H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007, 30, 527-535.
31. Barclay, A.N.; Wright, G.J.; Brooke, G.; Brown, M.H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 2002, 23, 285-290.
32. Hoek, R.M.; Ruuls, S.R.; Murphy, C.A.; Wright, G.J.; Goddard, R.; Zurawski, S.M.; Blom, B.; Homola, M.E.; Streit, W.J.; Brown, M.H.; Barclay, A.N.; Sedgwick, J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290, 1768-1771.
33. Wright, G.J.; Cherwinski, H.; Foster-Cuevas, M.; Brooke, G.; Puklavec, M.J.; Bigler, M.; Song, Y.; Jenmalm, M.; Gorman, D.; McClanahan, T., et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 2003, 171, 3034-3046.
34. Lyons, A.; Downer, E.J.; Crotty, S.; Nolan, Y.M.; Mills, K.H.; Lynch, M.A. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: A role for IL-4. J. Neurosci. 2007, 27, 8309-8313.
35. Hanisch, U.K.; Kettenmann, H. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10, 1387-1394.
36. Van Rossum, D.; Hanisch, U.K. Microglia. Metab. Brain Dis. 2004, 19, 393-411.
37. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783-801.
38. Ponomarev, E.D.; Shriver, L.P.; Dittel, B.N. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol. 2006, 176, 1402-1410.
39. Takeuchi, O.; Akira, S. Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 2001, 1, 625-635.
40. Bowman, C.C.; Rasley, A.; Tranguch, S.L.; Marriott, I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003, 43, 281-291.
41. Kielian, T.; Mayes, P.; Kielian, M. Characterization of microglial responses to Staphylococcus aureus: Effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J. Neuroimmunol. 2002, 130, 86-99.
42. Farina, C.; Krumbholz, M.; Giese, T.; Hartmann, G.; Aloisi, F.; Meinl, E. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 2005, 159, 12-19.
43. Lehnardt, S.; Henneke, P.; Lien, E.; Kasper, D.L.; Volpe, J.J.; Bechmann, I.; Nitsch, R.; Weber, J.R.; Golenbock, D.T.; Vartanian, T. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J. Immunol. 2006, 177, 583-592.
44. Lehnardt, S.; Lehmann, S.; Kaul, D.; Tschimmel, K.; Hoffmann, O.; Cho, S.; Krueger, C.; Nitsch, R.; Meisel, A.; Weber, J.R. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 2007, 190, 28-33.
45. Babcock, A.A.; Wirenfeldt, M.; Holm, T.; Nielsen, H.H.; Dissing-Olesen, L.; Toft-Hansen, H.; Millward, J.M.; Landmann, R.; Rivest, S.; Finsen, B., et al. Toll-like receptor 2 signaling in response to brain injury: An innate bridge to neuroinflammation. J. Neurosci. 2006, 26, 12826-12837.
46. Lehnardt, S.; Massillon, L.; Follett, P.; Jensen, F.E.; Ratan, R.; Rosenberg, P.A.; Volpe, J.J.; Vartanian, T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 2003, 100, 8514-8519.
47. Visintin, A.; Mazzoni, A.; Spitzer, J.H.; Wyllie, D.H.; Dower, S.K.; Segal, D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 2001, 166, 249-255.
48. Jack, C.S.; Arbour, N.; Manusow, J.; Montgrain, V.; Blain, M.; McCrea, E.; Shapiro, A.; Antel, J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005, 175, 4320-4330.
49. Caso, J.R.; Pradillo, J.M.; Hurtado, O.; Leza, J.C.; Moro, M.A.; Lizasoain, I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 2008, 39, 1314-1320.
50. Kilic, U.; Kilic, E.; Matter, C.M.; Bassetti, C.L.; Hermann, D.M. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol. Dis. 2008, 31, 33-40.
51. Lehnardt, S.; Schott, E.; Trimbuch, T.; Laubisch, D.; Krueger, C.; Wulczyn, G.; Nitsch, R.; Weber, J.R., A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 2008, 28, 2320-2331.
52. Pais, T.F.; Figueiredo, C.; Peixoto, R.; Braz, M.H.; Chatterjee, S. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflammation 2008, 5, 43.
53. Glezer, I.; Lapointe, A.; Rivest, S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 2006, 20, 750-752.
54. Saijo, K.; Winner, B.; Carson, C.T.; Collier, J.G.; Boyer, L.; Rosenfeld, M.G.; Gage, F.H.; Glass, C.K. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009, 137, 47-59.
55. Nawashiro, H.; Tasaki, K.; Ruetzler, C.A.; Hallenbeck, J.M. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 1997, 17, 483-490.
56. Glezer, I.; Simard, A.R.; Rivest, S. Neuroprotective role of the innate immune system by microglia. Neuroscience 2007, 147, 867-883.
57. McPherson, C.A.; Kraft, A.D.; Harry, G.J. Injury-induced neurogenesis: Consideration of resident microglia as supportive of neural progenitor cells. Neurotox. Res. 2011, 19, 341-352.
58. Landreth, G.E.; Reed-Geaghan, E.G. Toll-like receptors in Alzheimer's disease. Curr. Top. Microbiol. Immunol. 2009, 336, 137-153.
59. Reed-Geaghan, E.G.; Savage, J.C.; Hise, A.G.; Landreth, G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci. 2009, 29, 11982-11992.
60. Walter, S.; Letiembre, M.; Liu, Y.; Heine, H.; Penke, B.; Hao, W.; Bode, B.; Manietta, N.; Walter, J.; Schulz-Schuffer, W.; Fassbender, K. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol. Biochem. 2007, 20, 947-956.
61. Husemann, J.; Loike, J.D.; Anankov, R.; Febbraio, M.; Silverstein, S.C. Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system. Glia 2002, 40, 195-205.
62. Farber, K.; Kettenmann, H. Physiology of microglial cells. Brain Res. Brain Res. Rev. 2005, 48, 133-143.
63. Farber, K.; Pannasch, U.; Kettenmann, H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol. Cell Neurosci. 2005, 29, 128-138.
64. Noda, M.; Nakanishi, H.; Nabekura, J.; Akaike, N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J. Neurosci. 2000, 20, 251-258.
65. Di Virgilio, F.; Ceruti, S.; Bramanti, P.; Abbracchio, M.P. Purinergic signalling in inflammation of the central nervous system. Trends Neurosci. 2009, 32, 79-87.
66. Farber, K.; Kettenmann, H. Purinergic signaling and microglia. Pflugers Arch. 2006, 452, 615-621.
67. Kettenmann, H. Neuroscience: The brain's garbage men. Nature 2007, 446, 987-989.
68. Koizumi, S.; Shigemoto-Mogami, Y.; Nasu-Tada, K.; Shinozaki, Y.; Ohsawa, K.; Tsuda, M.; Joshi, B.V.; Jacobson, K.A.; Kohsaka, S.; Inoue, K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446, 1091-1095.
69. Neeper, M.; Schmidt, A.M.; Brett, J.; Yan, S.D.; Wang, F.; Pan, Y.C.; Elliston, K.; Stern, D.; Shaw, A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267, 14998-15004.
70. Schmidt, A.M.; Vianna, M.; Gerlach, M.; Brett, J.; Ryan, J.; Kao, J.; Esposito, C.; Hegarty, H.; Hurley, W.; Clauss, M., et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 1992, 267, 14987-14997.
71. Bu, G. Apolipoprotein E and its receptors in Alzheimer's disease: Pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009, 10, 333-344.
72. Schmidt, A.M.; Sahagan, B.; Nelson, R.B.; Selmer, J.; Rothlein, R.; Bell, J.M. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease. Curr. Opin. Investig. Drugs 2009, 10, 672-680.
73. Srikanth, V.; Maczurek, A.; Phan, T.; Steele, M.; Westcott, B.; Juskiw, D.; Munch, G. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol. Aging 2011, 32, 763-777.
74. Halle, A.; Hornung, V.; Petzold, G.C.; Stewart, C.R.; Monks, B.G.; Reinheckel, T.; Fitzgerald, K.A.; Latz, E.; Moore, K.J.; Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9, 857-865.
75. Ravichandran, K.S. "Recruitment signals" from apoptotic cells: Invitation to a quiet meal. Cell 2003, 113, 817-820.
76. Miyanishi, M.; Tada, K.; Koike, M.; Uchiyama, Y.; Kitamura, T.; Nagata, S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007, 450, 435-439.
77. Takahashi, K.; Rochford, C.D.; Neumann, H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201, 647-657.
78. Neumann, H.; Takahashi, K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J. Neuroimmunol. 2007, 184, 92-99.
79. Butovsky, O.; Koronyo-Hamaoui, M.; Kunis, G.; Ophir, E.; Landa, G.; Cohen, H.; Schwartz, M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA 2006, 103, 11784-11789.
80. Hanisch, U.K. Microglia as a source and target of cytokines. Glia 2002, 40, 140-155.
81. Liberto, C.M.; Albrecht, P.J.; Herx, L.M.; Yong, V.W.; Levison, S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 2004, 89, 1092-1100.
82. Wee Yong, V. Inflammation in neurological disorders: A help or a hindrance? Neuroscientist 2010, 16, 408-420.
83. Heese, K.; Hock, C.; Otten, U. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 1998, 70, 699-707.
84. Owens, T.; Babcock, A.A.; Millward, J.M.; Toft-Hansen, H. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res. Brain Res. Rev. 2005, 48, 178-184.
85. Herx, L.M.; Rivest, S.; Yong, V.W. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 2000, 165, 2232-2239.
86. McGuire, S.O.; Ling, Z.D.; Lipton, J.W.; Sortwell, C.E.; Collier, T.J.; Carvey, P.M. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp. Neurol. 2001, 169, 219-230.
87. Bruce, A.J.; Boling, W.; Kindy, M.S.; Peschon, J.; Kraemer, P.J.; Carpenter, M.K.; Holtsberg, F.W.; Mattson, M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 1996, 2, 788-794.
88. Mattson, M.P.; Cheng, B.; Baldwin, S.A.; Smith-Swintosky, V.L.; Keller, J.; Geddes, J.W.; Scheff, S.W.; Christakos, S. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: Evidence for a cytoprotective response. J. Neurosci. Res. 1995, 42, 357-370.
89. Sullivan, P.G.; Bruce-Keller, A.J.; Rabchevsky, A.G.; Christakos, S.; Clair, D.K.; Mattson, M.P.; Scheff, S.W. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 1999, 19, 6248-6256.
90. 2+ accumulation. Proc. Natl. Acad. Sci. USA 1995, 92, 9328-9332.
91. Cheng, B.; Christakos, S.; Mattson, M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12, 139-153.
92. Shohami, E.; Bass, R.; Wallach, D.; Yamin, A.; Gallily, R. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 1996, 16, 378-384.
93. Venters, H.D.; Dantzer, R.; Kelley, K.W. A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci. 2000, 23, 175-180.
94. Harry, G.J.; Lefebvre d'Hellencourt, C.; McPherson, C.A.; Funk, J.A.; Aoyama, M.; Wine, R.N. Tumor necrosis factor p55 and p75 receptors are involved in chemical-induced apoptosis of dentate granule neurons. J. Neurochem. 2008, 106, 281-298.
95. Taupin, P. A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. Cent. Nerv. Syst. Agents Med. Chem. 2010, 10, 16-21.
96. Lipton, S.A.; Gu, Z.; Nakamura, T. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders. Int. Rev. Neurobiol. 2007, 82, 1-27.
97. Colton, C.; Wilt, S.; Gilbert, D.; Chernyshev, O.; Snell, J.; Dubois-Dalcq, M. Species differences in the generation of reactive oxygen species by microglia. Mol. Chem. Neuropathol. 1996, 28, 15-20.
98. Marin-Teva, J.L.; Dusart, I.; Colin, C.; Gervais, A.; van Rooijen, N.; Mallat, M. Microglia promote the death of developing Purkinje cells. Neuron 2004, 41, 535-547.
99. Guyton, K.Z.; Gorospe, M.; Kensler, T.W.; Holbrook, N.J. Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: Implications for cellular survival and tumor promotion. Cancer Res. 1996, 56, 3480-3485.
100. Konishi, H.; Tanaka, M.; Takemura, Y.; Matsuzaki, H.; Ono, Y.; Kikkawa, U.; Nishizuka, Y. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. USA 1997, 94, 11233-11237.
101. Schreck, R.; Rieber, P.; Baeuerle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991, 10, 2247-2258.
102. Infanger, D.W.; Sharma, R.V.; Davisson, R.L. NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid. Redox Signal. 2006, 8, 1583-1596.
103. Choi, S.H.; Lee, D.Y.; Kim, S.U.; Jin, B.K. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: Role of microglial NADPH oxidase. J. Neurosc. 2005, 25, 4082-4090.
104. Park, K.W.; Jin, B.K. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: Role of neuronal NADPH oxidase. J. Neurosci. Res. 2008, 86, 1053-1063.
105. Lambeth, J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4, 181-189.
106. Sumimoto, H.; Ueno, N.; Yamasaki, T.; Taura, M.; Takeya, R. Molecular mechanism underlying activation of superoxide-producing NADPH oxidases: Roles for their regulatory proteins. Jpn. J. Infect. Dis. 2004, 57, S24-25.
107. Colton, C.A.; Gilbert, D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 1987, 223, 284-288.
108. 2+ channels. Am. J. Physiol. 1994, 266, C1650-1655.
109. + channels and the microglial respiratory burst. Am. J. Physiol. Cell Physiol. 2001, 280, C796-806.
110. Shatwell, K.P.; Segal, A.W. NADPH oxidase. Int. J. Biochem. Cell. Biol. 1996, 28, 1191-1195.
111. Brown, G.C.; Neher, J.J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 2010, 41, 242-247.
112. Lee, H.G.; Won, S.M.; Gwag, B.J.; Lee, Y.B. Microglial P2X7 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease. Exp. Mol. Med. 2011, 43, 7-14.
113. Schilling, T.; Eder, C. Stimulus-dependent requirement of ion channels for microglial NADPH oxidase-mediated production of reactive oxygen species. J. Neuroimmunol. 2010, 225, 190-194.
114. Skaper, S.D. Ion channels on microglia: Therapeutic targets for neuroprotection. CNS Neurol. Disord. Drug Targets 2011, 10, 44-56.
115. Fordyce, C.B.; Jagasia, R.; Zhu, X.; Schlichter, L.C. Microglia Kv1.3 channels contribute to their ability to kill neurons. J. Neurosci. 2005, 25, 7139-7149.
116. Parvathenani, L.K.; Tertyshnikova, S.; Greco, C.R.; Roberts, S.B.; Robertson, B.; Posmantur, R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 2003, 278, 13309-13317.
117. Brown, G.C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 2007, 35, 1119-1121.
118. Savill, J.; Gregory, C.; Haslett, C. Cell biology. Eat me or die. Science 2003, 302, 1516-1517.
119. Barger, S.W.; Goodwin, M.E.; Porter, M.M.; Beggs, M.L. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 2007, 101, 1205-1213.
120. Miller, R.L.; James-Kracke, M.; Sun, G.Y.; Sun, A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 2009, 34, 55-65.
121. Qin, L.; Liu, Y.; Wang, T.; Wei, S.J.; Block, M.L.; Wilson, B.; Liu, B.; Hong, J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 2004, 279, 1415-1421.
122. Tieu, K.; Ischiropoulos, H.; Przedborski, S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 2003, 55, 329-335.
123. Mander, P.; Brown, G.C. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: A dual-key mechanism of inflammatory neurodegeneration. J. Neuroinflammation 2005, 2, 20.
124. Chung, Y.C.; Kim, S.R.; Jin, B.K. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J. Immunol. 2010, 185, 1230-1237.
125. Jekabsone, A.; Mander, P.K.; Tickler, A.; Sharpe, M.; Brown, G.C. Fibrillar beta-amyloid peptide Abeta1-40 activates microglial proliferation via stimulating TNF-alpha release and H2O2 derived from NADPH oxidase: A cell culture study. J. Neuroinflammation 2006, 3, 24.
126. Mander, P.K.; Jekabsone, A.; Brown, G.C. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J. Immunol. 2006, 176, 1046-1052.
127. Bal-Price, A.; Matthias, A.; Brown, G.C. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J. Neurochem. 2002, 80, 73-80.
128. Gobbel, G.T.; Chan, T.Y.; Chan, P.H. Nitric oxide- and superoxide-mediated toxicity in cerebral endothelial cells. J. Pharmacol. Exp. Ther. 1997, 282, 1600-1607.
129. Tarpey, M.M.; Wink, D.A.; Grisham, M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286, R431-444.
130. Lee, S.; Suk, K. Heme oxygenase-1 mediates cytoprotective effects of immunostimulation in microglia. Biochem. Pharmacol. 2007, 74, 723-729.
131. Noda, M.; Doi, Y.; Liang, J.; Kawanokuchi, J.; Sonobe, Y.; Takeuchi, H.; Mizuno, T.; Suzumura, A. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 2011, 286, 2308-2319.
132. Basuroy, S.; Tcheranova, D.; Bhattacharya, S.; Leffler, C.W.; Parfenova, H. Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-alpha-induced apoptosis. Am. J. Physiol. Cell Physiol. 2011, 300, C256-265.
133. Leffler, C.W.; Parfenova, H.; Jaggar, J.H. Carbon monoxide as an endogenous vascular modulator. Am. J. Physiol. Heart Circ. Physiol. 2011, 301, H1-H11.
134. Vieira, H.L.; Queiroga, C.S.; Alves, P.M. Pre-conditioning induced by carbon monoxide provides neuronal protection against apoptosis. J. Neurochem. 2008, 107, 375-384.
135. Zeynalov, E.; Dore, S. Low doses of carbon monoxide protect against experimental focal brain ischemia. Neurotox. Res. 2009, 15, 133-137.
136. Syapin, P.J. Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 2008, 155, 623-640.
137. Guix, F.X.; Uribesalgo, I.; Coma, M.; Munoz, F.J. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 2005, 76, 126-152.
138. Bon, C.L.; Garthwaite, J. On the role of nitric oxide in hippocampal long-term potentiation. J. Neurosci. 2003, 23, 1941-1948.
139. Calabrese, V.; Mancuso, C.; Calvani, M.; Rizzarelli, E.; Butterfield, D.A.; Stella, A.M. Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8, 766-775.
140. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47-95.
141. Tichauer, J.; Saud, K.; von Bernhardi, R. Modulation by astrocytes of microglial cell-mediated neuroinflammation: Effect on the activation of microglial signaling pathways. Neuroimmunomodulation 2007, 14, 168-174.
142. Murphy, S. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. Glia 2000, 29, 1-13.
143. Heneka, M.T.; Feinstein, D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 2001, 114, 8-18.
144. Nussler, A.K.; Billiar, T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 1993, 54, 171-178.
145. Vitek, M.P.; Brown, C.; Xu, Q.; Dawson, H.; Mitsuda, N.; Colton, C.A. Characterization of NO and cytokine production in immune-activated microglia and peritoneal macrophages derived from a mouse model expressing the human NOS2 gene on a mouse NOS2 knockout background. Antioxid. Redox Signal. 2006, 8, 893-901.
146. Cho, S.; Park, E.M.; Zhou, P.; Frys, K.; Ross, M.E.; Iadecola, C. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J. Cereb. Blood Flow Metab. 2005, 25, 493-501.
147. Colton, C.A. Induction of nitric oxide in cultured microglia: Evidence for a cytoprotective role. Adv. Neuroimmunol. 1995, 5, 491-503.
148. Thiel, V.E.; Audus, K.L. Nitric oxide and blood-brain barrier integrity. Antioxid. Redox Signal. 2001, 3, 273-278.
149. Merrill, J.E.; Ignarro, L.J.; Sherman, M.P.; Melinek, J.; Lane, T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 1993, 151, 2132-2141.
150. Bal-Price, A.; Brown, G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 2001, 21, 6480-6491.
151. Bal-Price, A.; Moneer, Z.; Brown, G.C. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 2002, 40, 312-323.
152. Colton, C.A.; Wilcock, D.M. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 2010, 9, 174-191.
153. Broom, L.; Marinova-Mutafchieva, L.; Sadeghian, M.; Davis, J.B.; Medhurst, A.D.; Dexter, D.T. Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease. Free Radic. Biol. Med. 2011, 50, 633-640.
154. Ebadi, M.; Sharma, S.K. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid. Redox Signal. 2003, 5, 319-335.
155. L'Episcopo, F.; Tirolo, C.; Caniglia, S.; Testa, N.; Serra, P.A.; Impagnatiello, F.; Morale, M.C.; Marchetti, B. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neuroinflammation 2010, 7, 83.
156. Farooqui, T.; Farooqui, A.A. Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis. 2011, 2011, 247-467.
157. Adams, R.A.; Bauer, J.; Flick, M.J.; Sikorski, S.L.; Nuriel, T.; Lassmann, H.; Degen, J.L.; Akassoglou, K. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J. Exp. Med. 2007, 204, 571-582.
158. Ransohoff, R.M.; Perry, V.H. Microglial physiology: Unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27, 119-145.
159. Ryu, J.K.; Davalos, D.; Akassoglou, K. Fibrinogen signal transduction in the nervous system. J. Thromb. Haemost. 2009, 7 (Suppl 1), 151-154.
160. Ryu, J.K.; McLarnon, J.G. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell Mol. Med. 2009, 13, 2911-2925.
161. Chan, W.Y.; Kohsaka, S.; Rezaie, P. The origin and cell lineage of microglia: New concepts. Brain Res. Rev. 2007, 53, 344-354.
162. Flugel, A.; Bradl, M.; Kreutzberg, G.W.; Graeber, M.B. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J. Neurosci. Res. 2001, 66, 74-82.
163. Carson, M.J.; Reilly, C.R.; Sutcliffe, J.G.; Lo, D. Mature microglia resemble immature antigen-presenting cells. Glia 1998, 22, 72-85.
164. 4+ T cells compared. J. Immunol. 1995, 154, 4309-4321.
165. Simard, A.R.; Rivest, S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 2004, 18, 998-1000.
166. Ajami, B.; Bennett, J.L.; Krieger, C.; Tetzlaff, W.; Rossi, F.M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 2007, 10, 1538-1543.
167. 2+ monocytes only under defined host conditions. Nat. Neurosci. 2007, 10, 1544-1553.
168. Schmid, C.D.; Melchior, B.; Masek, K.; Puntambekar, S.S.; Danielson, P.E.; Lo, D.D.; Sutcliffe, J.G.; Carson, M.J. Differential gene expression in LPS/IFNgamma activated microglia and macrophages: In vitro versus in vivo. J. Neurochem. 2009, 109 (Suppl 1), 117-125.
169. Carson, M.J.; Bilousova, T.V.; Puntambekar, S.S.; Melchior, B.; Doose, J.M.; Ethell, I.M. A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 2007, 4, 571-579.
170. El Khoury, J.; Luster, A.D. Mechanisms of microglia accumulation in Alzheimer's disease: Therapeutic implications. Trends Pharmacol. Sci. 2008, 29, 626-632.
171. El Khoury, J.; Toft, M.; Hickman, S.E.; Means, T.K.; Terada, K.; Geula, C.; Luster, A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007, 13, 432-438.
172. Kochanek, P.M.; Hallenbeck, J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992, 23, 1367-1379.
173. Stoll, G.; Jander, S.; Schroeter, M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 2002, 513, 87-113.
174. Graeber, M.B.; Lopez-Redondo, F.; Ikoma, E.; Ishikawa, M.; Imai, Y.; Nakajima, K.; Kreutzberg, G.W.; Kohsaka, S. The microglia/macrophage response in the neonatal rat facial nucleus following axotomy. Brain Res. 1998, 813, 241-253.
175. Ransohoff, R.M. Microgliosis: The questions shape the answers. Nat. Neurosci. 2007, 10, 1507-1509.
176. Funk, J.A.; Gohlke, J.; Kraft, A.D.; McPherson, C.A.; Collins, J.B.; Jean Harry, G. Voluntary exercise protects hippocampal neurons from trimethyltin injury: Possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity. Brain Behav. Immun. 2011, in press.
177. Carson, M.J. Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis. Glia 2002, 40, 218-231.
178. Danton, G.H.; Dietrich, W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 2003, 62, 127-136.
179. Gonzalez-Scarano, F.; Baltuch, G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 1999, 22, 219-240.
180. Thomas, W.E. Brain macrophages: Evaluation of microglia and their functions. Brain Res. Brain Res. Rev. 1992, 17, 61-74.
181. Rivest, S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9, 429-439.
182. Town, T.; Nikolic, V.; Tan, J. The microglial "activation" continuum: From innate to adaptive responses. J. Neuroinflammation 2005, 2, 24.
183. Chu, Y.; Jin, X.; Parada, I.; Pesic, A.; Stevens, B.; Barres, B.; Prince, D.A. Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc. Natl. Acad. Sci. USA 2010, 107, 7975-7980.
184. Wake, H.; Moorhouse, A.J.; Jinno, S.; Kohsaka, S.; Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29, 3974-3980.
185. Tremblay, M.E.; Lowery, R.L.; Majewska, A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8, e1000527:1-e1000527:16.
186. Stevens, B.; Allen, N.J.; Vazquez, L.E.; Howell, G.R.; Christopherson, K.S.; Nouri, N.; Micheva, K.D.; Mehalow, A.K.; Huberman, A.D.; Stafford, B., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131, 1164-1178.
187. Kraft, A.D.; Kaltenbach, L.S.; Lo, D.C.; Harry, G.J. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Neurobiol. Aging 2011, in press.
188. Perry, V.H.; O'Connor, V. The role of microglia in synaptic stripping and synaptic degeneration: A revised perspective. ASN Neuro. 2010, 2, 281-291.
189. Meyer-Luehmann, M.; Spires-Jones, T.L.; Prada, C.; Garcia-Alloza, M.; de Calignon, A.; Rozkalne, A.; Koenigsknecht-Talboo, J.; Holtzman, D.M.; Bacskai, B.J.; Hyman, B.T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451, 720-724.
190. Damani, M.R.; Zhao, L.; Fontainhas, A.M.; Amaral, J.; Fariss, R.N.; Wong, W.T. Age-related alterations in the dynamic behavior of microglia. Aging Cell 2011, 10, 263-276.
191. Streit, W.J.; Miller, K.R.; Lopes, K.O.; Njie, E. Microglial degeneration in the aging brain-bad news for neurons? Front. Biosci. 2008, 13, 3423-3438.
192. Ryu, J.K.; McLarnon, J.G. Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus. Exp. Neurol. 2006, 198, 552-557.
193. Yong, V.W.; Wells, J.; Giuliani, F.; Casha, S.; Power, C.; Metz, L.M. The promise of minocycline in neurology. Lancet Neurol. 2004, 3, 744-751.
194. Wasserman, J.K.; Schlichter, L.C. Minocycline protects the blood-brain barrier and reduces edema following intracerebral hemorrhage in the rat. Exp. Neurol. 2007, 207, 227-237.
195. Hirsch, E.C.; Hunot, S. Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol. 2009, 8, 382-397.
196. Du, Y.; Ma, Z.; Lin, S.; Dodel, R.C.; Gao, F.; Bales, K.R.; Triarhou, L.C.; Chernet, E.; Perry, K.W.; Nelson, D.L., et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 2001, 98, 14669-14674.
197. He, Y.; Appel, S.; Le, W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 2001, 909, 187-193.
198. Wu, D.C.; Jackson-Lewis, V.; Vila, M.; Tieu, K.; Teismann, P.; Vadseth, C.; Choi, D.K.; Ischiropoulos, H.; Przedborski, S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 2002, 22, 1763-1771.
199. Liou, H.H.; Chen, R.C.; Tsai, Y.F.; Chen, W.P.; Chang, Y.C.; Tsai, M.C. Effects of paraquat on the substantia nigra of the wistar rats: Neurochemical, histological, and behavioral studies. Toxicol. Appl. Pharmacol. 1996, 137, 34-41.
200. McCormack, A.L.; Thiruchelvam, M.; Manning-Bog, A.B.; Thiffault, C.; Langston, J.W.; Cory-Slechta, D.A.; di Monte, D.A. Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 2002, 10, 119-127.
201. Purisai, M.G.; McCormack, A.L.; Cumine, S.; Li, J.; Isla, M.Z.; Di Monte, D.A. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol. Dis. 2007, 25, 392-400.
202. Saint-Pierre, M.; Tremblay, M.E.; Sik, A.; Gross, R.E.; Cicchetti, F. Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats. J. Neurochem. 2006, 98, 760-772.
203. Thiruchelvam, M.; Richfield, E.K.; Baggs, R.B.; Tank, A.W.; Cory-Slechta, D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease. J. Neurosci. 2000, 20, 9207-9214.
204. Mangano, E.N.; Hayley, S. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Neurobiol. Aging 2009, 30, 1361-1378.
205. Casarejos, M.J.; Menendez, J.; Solano, R.M.; Rodriguez-Navarro, J.A.; Garcia de Yebenes, J.; Mena, M.A. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J. Neurochem. 2006, 97, 934-946.
206. O'Callaghan, J.P.; Sriram, K.; Miller, D.B. Defining "neuroinflammation". Ann. NY Acad. Sci. 2008, 1139, 318-330.
207. Boger, H.A.; Middaugh, L.D.; Granholm, A.C.; McGinty, J.F. Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol. Dis. 2009, 33, 459-466.
208. Chen, X.; Ma, X.; Jiang, Y.; Pi, R.; Liu, Y.; Ma, L. The prospects of minocycline in multiple sclerosis. J. Neuroimmunol. 2011, 235, 1-8.
209. Yenari, M.A.; Xu, L.; Tang, X.N.; Qiao, Y.; Giffard, R.G. Microglia potentiate damage to blood-brain barrier constituents: Improvement by minocycline in vivo and in vitro. Stroke 2006, 37, 1087-1093.
210. Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140, 918-934.
211. Rao, J.S.; Harry, G.J.; Rapoport, S.I.; Kim, H.W. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 2010, 15, 384-392.
212. Graeber, M.B.; Streit, W.J. Microglia: Biology and pathology. Acta Neuropathol. 2010, 119, 89-105.
213. Yan, P.; Bero, A.W.; Cirrito, J.R.; Xiao, Q.; Hu, X.; Wang, Y.; Gonzales, E.; Holtzman, D.M.; Lee, J.M. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J. Neurosci. 2009, 29, 10706-10714.
214. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G.M.; Cooper, N.R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B.L., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21, 383-421.
215. Eikelenboom, P.; Zhan, S.S.; Kamphorst, W.; van der Valk, P.; Rozemuller, J.M. Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch. 1994, 424, 421-427.
216. Eikelenboom, P.; Zhan, S.S.; van Gool, W.A.; Allsop, D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 1994, 15, 447-450.
217. Williams, A.E.; Ryder, S.; Blakemore, W.F. Monocyte recruitment into the scrapie-affected brain. Acta Neuropathol. 1995, 90, 164-169.
218. Betmouni, S.; Perry, V.H.; Gordon, J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996, 74, 1-5.
219. Williams, A.E.; Lawson, L.J.; Perry, V.H.; Fraser, H. Characterization of the microglial response in murine scrapie. Neuropathol. Appl. Neurobiol. 1994, 20, 47-55.
220. McCoy, M.K.; Tansey, M.G. TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 2008, 5, 45.
221. Simi, A.; Tsakiri, N.; Wang, P.; Rothwell, N.J. Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans. 2007, 35, 1122-1126.
222. McGeer, P.L.; McGeer, E.G. Inflammation and the degenerative diseases of aging. Ann. NY Acad. Sci. 2004, 1035, 104-116.
223. Lee, C.Y.; Landreth, G.E. The role of microglia in amyloid clearance from the AD brain. J. Neural. Transm. 2010, 117, 949-960.
224. Naert, G.; Rivest, S. The role of microglial cell subsets in Alzheimer's disease. Curr. Alzheimer Res. 2011, 8, 151-155.
225. Persaud-Sawin, D.A.; Banach, L.; Harry, G.J. Raft aggregation with specific receptor recruitment is required for microglial phagocytosis of Abeta42. Glia 2009, 57, 320-335.
226. Imbimbo, B.P. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Expert Opin. Investig. Drugs 2009, 18, 1147-1168.
227. Sonnen, J.A.; Larson, E.B.; Walker, R.L.; Haneuse, S.; Crane, P.K.; Gray, S.L.; Breitner, J.C.; Montine, T.J. Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology 2010, 75, 1203-1210.
228. Zilka, N.; Ferencik, M.; Hulin, I. Neuroinflammation in Alzheimer's disease: Protector or promoter? Bratisl. Lek. Listy 2006, 107, 374-383.
229. Grathwohl, S.A.; Kalin, R.E.; Bolmont, T.; Prokop, S.; Winkelmann, G.; Kaeser, S.A.; Odenthal, J.; Radde, R.; Eldh, T.; Gandy, S., et al. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat. Neurosci. 2009, 12, 1361-1363.
230. Wyss-Coray, T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat. Med. 2006, 12, 1005-1015.
231. Guilarte, T.R. Manganese and Parkinson's disease: A critical review and new findings. Environ. Health Perspect. 2010, 118, 1071-1080.
232. Greenamyre, J.T.; Cannon, J.R.; Drolet, R.; Mastroberardino, P.G. Lessons from the rotenone model of Parkinson's disease. Trends Pharmacol. Sci. 2010, 31, 141-142; author reply 142-143.
233. Schmidt, W.J.; Alam, M. Controversies on new animal models of Parkinson's disease pro and con: The rotenone model of Parkinson's disease (PD). J. Neural. Transm. Suppl. 2006, 70, 272-276.
234. Aschner, M.; Guilarte, T.R.; Schneider, J.S.; Zheng, W. Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 2007, 221, 131-147.
235. Perl, D.P.; Olanow, C.W. The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 2007, 66, 675-682.
236. Calne, D.B.; Chu, N.S.; Huang, C.C.; Lu, C.S.; Olanow, W. Manganism and idiopathic parkinsonism: Similarities and differences. Neurology 1994, 44, 1583-1586.
237. Cersosimo, M.G.; Koller, W.C. The diagnosis of manganese-induced parkinsonism. Neurotoxicology 2006, 27, 340-346.
238. Pal, P.K.; Samii, A.; Calne, D.B. Manganese neurotoxicity: A review of clinical features, imaging and pathology. Neurotoxicology 1999, 20, 227-238.
239. Olanow, C.W.; Good, P.F.; Shinotoh, H.; Hewitt, K.A.; Vingerhoets, F.; Snow, B.J.; Beal, M.F.; Calne, D.B.; Perl, D.P. Manganese intoxication in the rhesus monkey: A clinical, imaging, pathologic, and biochemical study. Neurology 1996, 46, 492-498.
240. Guilarte, T.R.; Burton, N.C.; McGlothan, J.L.; Verina, T.; Zhou, Y.; Alexander, M.; Pham, L.; Griswold, M.; Wong, D.F.; Syversen, T., et al. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism. J. Neurochem. 2008, 107, 1236-1247.
241. Guilarte, T.R.; Chen, M.K.; McGlothan, J.L.; Verina, T.; Wong, D.F.; Zhou, Y.; Alexander, M.; Rohde, C.A.; Syversen, T.; Decamp, E., et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 2006, 202, 381-390.
242. Verina, T.; Kiihl, S.F.; Schneider, J.S.; Guilarte, T.R. Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 2011, 32, 215-226.
243. Lopes, K.O.; Sparks, D.L.; Streit, W.J. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 2008, 56, 1048-1060.
244. Sriram, K.; Lin, G.X.; Jefferson, A.M.; Roberts, J.R.; Chapman, R.S.; Chen, B.T.; Soukup, J.M.; Ghio, A.J.; Antonini, J.M. Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Arch. Toxicol. 2010, 84, 521-540.
245. Chang, J.Y.; Liu, L.Z. Manganese potentiates nitric oxide production by microglia. Brain Res. Mol. Brain Res. 1999, 68, 22-28.
246. Crittenden, P.L.; Filipov, N.M. Manganese-induced potentiation of in vitro proinflammatory cytokine production by activated microglial cells is associated with persistent activation of p38 MAPK. Toxicol. In Vitro 2008, 22, 18-27.
247. Zhang, P.; Lokuta, K.M.; Turner, D.E.; Liu, B. Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: Differential involvement of microglia and astroglia. J. Neurochem. 2010, 112, 434-443.
248. Hesterberg, T.W.; Bunn, W.B., 3rd; Chase, G.R.; Valberg, P.A.; Slavin, T.J.; Lapin, C.A.; Hart, G.A. A critical assessment of studies on the carcinogenic potential of diesel exhaust. Crit. Rev. Toxicol. 2006, 36, 727-776.
249. Hartz, A.M.; Bauer, B.; Block, M.L.; Hong, J.S.; Miller, D.S. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J. 2008, 22, 2723-2733.
250. Block, M.L.; Wu, X.; Pei, Z.; Li, G.; Wang, T.; Qin, L.; Wilson, B.; Yang, J.; Hong, J.S.; Veronesi, B. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: The role of microglia, phagocytosis, and NADPH oxidase. FASEB J. 2004, 18, 1618-1620.
251. Aloisi, F. Immune function of microglia. Glia 2001, 36, 165-179.
252. Becher, B.; Antel, J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 1996, 18, 1-10.
253. Long, T.C.; Tajuba, J.; Sama, P.; Saleh, N.; Swartz, C.; Parker, J.; Hester, S.; Lowry, G.V.; Veronesi, B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ. Health Perspect. 2007, 115, 1631-1637.
254. Campbell, A.; Oldham, M.; Becaria, A.; Bondy, S.C.; Meacher, D.; Sioutas, C.; Misra, C.; Mendez, L.B.; Kleinman, M. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 2005, 26, 133-140.
255. Guastadisegni, C.; Kelly, F.J.; Cassee, F.R.; Gerlofs-Nijland, M.E.; Janssen, N.A.; Pozzi, R.; Brunekreef, B.; Sandstrom, T.; Mudway, I. Determinants of the proinflammatory action of ambient particulate matter in immortalized murine macrophages. Environ. Health Perspect. 2010, 118, 1728-1734.
256. Gerlofs-Nijland, M.E.; van Berlo, D.; Cassee, F.R.; Schins, R.P.; Wang, K.; Campbell, A. Effect of prolonged exposure to diesel engine exhaust on proinflammatory markers in different regions of the rat brain. Part. Fibre Toxicol. 2010, 7, 12.
257. Kida, S.; Steart, P.V.; Zhang, E.T.; Weller, R.O. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol. 1993, 85, 646-652.
258. Brunssen, S.H.; Morgan, D.L.; Parham, F.M.; Harry, G.J. Carbon monoxide neurotoxicity: Transient inhibition of avoidance response and delayed microglia reaction in the absence of neuronal death. Toxicology 2003, 194, 51-63.
259. Calderon-Garciduenas, L.; D'Angiulli, A.; Kulesza, R.J.; Torres-Jardon, R.; Osnaya, N.; Romero, L.; Keefe, S.; Herritt, L.; Brooks, D.M.; Avila-Ramirez, J., et al. Air pollution is associated with brainstem auditory nuclei pathology and delayed brainstem auditory evoked potentials. Int. J. Dev. Neurosci. 2011, 29, 365-375.
260. Calderon-Garciduenas, L.; Macias-Parra, M.; Hoffmann, H.J.; Valencia-Salazar, G.; Henriquez-Roldan, C.; Osnaya, N.; Monte, O.C.; Barragan-Mejia, G.; Villarreal-Calderon, R.; Romero, L., et al. Immunotoxicity and environment: Immunodysregulation and systemic inflammation in children. Toxicol. Pathol. 2009, 37, 161-169.
261. Finch, G.L.; Hobbs, C.H.; Blair, L.F.; Barr, E.B.; Hahn, F.F.; Jaramillo, R.J.; Kubatko, J.E.; March, T.H.; White, R.K.; Krone, J.R., et al. Effects of subchronic inhalation exposure of rats to emissions from a diesel engine burning soybean oil-derived biodiesel fuel. Inhal. Toxicol. 2002, 14, 1017-1048.
262. Jensen, L.K.; Klausen, H.; Elsnab, C. Organic brain damage in garage workers after long-term exposure to diesel exhaust fumes. Ugeskr Laeger 1989, 151, 2255-2258.
263. Calderon-Garciduenas, L.; Azzarelli, B.; Acuna, H.; Garcia, R.; Gambling, T.M.; Osnaya, N.; Monroy, S.; Del Tizapantzi, M.R.; Carson, J. L.; Villarreal-Calderon, A., et al. Air pollution and brain damage. Toxicol. Pathol. 2002, 30, 373-389.
264. Calderon-Garciduenas, L.; Solt, A.C.; Henriquez-Roldan, C.; Torres-Jardon, R.; Nuse, B.; Herritt, L.; Villarreal-Calderon, R.; Osnaya, N.; Stone, I.; Garcia, R., et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol. Pathol. 2008, 36, 289-310.
265. Takenaka, S.; Karg, E.; Roth, C.; Schulz, H.; Ziesenis, A.; Heinzmann, U.; Schramel, P.; Heyder, J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 2001, 109(Suppl 4), 547-551.
266. Calderon-Garciduenas, L.; Mora-Tiscareno, A.; Gomez-Garza, G.; Carrasco-Portugal M del, C.; Perez-Guille, B.; Flores-Murrieta, F.J.; Perez-Guille, G.; Osnaya, N.; Juarez-Olguin, H.; Monroy, M.E., et al. Effects of a cyclooxygenase-2 preferential inhibitor in young healthy dogs exposed to air pollution: A pilot study. Toxicol. Pathol. 2009, 37, 644-660.
267. Calderon-Garciduenas, L.; Mora-Tiscareno, A.; Ontiveros, E.; Gomez-Garza, G.; Barragan-Mejia, G.; Broadway, J.; Chapman, S.; Valencia-Salazar, G.; Jewells, V.; Maronpot, R.R., et al. Air pollution, cognitive deficits and brain abnormalities: A pilot study with children and dogs. Brain Cogn. 2008, 68, 117-127.
268. Hesterberg, T.W.; Long, C.M.; Bunn, W.B.; Sax, S.N.; Lapin, C.A.; Valberg, P.A. Non-cancer health effects of diesel exhaust: A critical assessment of recent human and animal toxicological literature. Crit. Rev. Toxicol. 2009, 39, 195-227.
269. Campen, M.J.; Babu, N.S.; Helms, G.A.; Pett, S.; Wernly, J.; Mehran, R.; McDonald, J.D. Nonparticulate components of diesel exhaust promote constriction in coronary arteries from ApoE-/- mice. Toxicol. Sci. 2005, 88, 95-102.
270. Cherng, T.W.; Paffett, M.L.; Jackson-Weaver, O.; Campen, M.J.; Walker, B.R.; Kanagy, N.L. Mechanisms of diesel-induced endothelial nitric oxide synthase dysfunction in coronary arterioles. Environ. Health Perspect. 2011, 119, 98-103.
271. Mills, N.L.; Tornqvist, H.; Robinson, S.D.; Gonzalez, M.; Darnley, K.; MacNee, W.; Boon, N.A.; Donaldson, K.; Blomberg, A.; Sandstrom, T., et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 2005, 112, 3930-3936.
272. Lehmann, A.D.; Blank, F.; Baum, O.; Gehr, P.; Rothen-Rutishauser, B.M. Diesel exhaust particles modulate the tight junction protein occludin in lung cells in vitro. Part. Fibre Toxicol. 2009, 6, 26.
273. Amara, N.; Bachoual, R.; Desmard, M.; Golda, S.; Guichard, C.; Lanone, S.; Aubier, M.; Ogier-Denis, E.; Boczkowski, J. Diesel exhaust particles induce matrix metalloprotease-1 in human lung epithelial cells via a NADP(H) oxidase/NOX4 redox-dependent mechanism. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293, L170-181.
274. Bayram, H.; Devalia, J.L.; Sapsford, R.J.; Ohtoshi, T.; Miyabara, Y.; Sagai, M.; Davies, R.J. The effect of diesel exhaust particles on cell function and release of inflammatory mediators from human bronchial epithelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 1998, 18, 441-448.
275. Joris, I.; Zand, T.; Nunnari, J.J.; Krolikowski, F.J.; Majno, G. Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am. J. Pathol. 1983, 113, 341-358.
276. Lippmann, M.; Gordon, T.; Chen, L.C. Effects of subchronic exposures to concentrated ambient particles in mice. IX. Integral assessment and human health implications of subchronic exposures of mice to CAPs. Inhal. Toxicol. 2005, 17, 255-261.
277. Streit, W.J.; Sparks, D.L. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 1997, 75, 130-138.
278. Sama, P.; Long, T.C.; Hester, S.; Tajuba, J.; Parker, J.; Chen, L.C.; Veronesi, B. The cellular and genomic response of an immortalized microglia cell line (BV2) to concentrated ambient particulate matter. Inhal. Toxicol. 2007, 19, 1079-1087.
279. Donaldson, K. The biological effects of coarse and fine particulate matter. Occup. Environ. Med. 2003, 60, 313-314.
280. Aschner, M.; Allen, J.W.; Kimelberg, H.K.; LoPachin, R.M.; Streit, W.J. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 151-173.
281. Schwartz, M.; Butovsky, O.; Bruck, W.; Hanisch, U.K. Microglial phenotype: Is the commitment reversible? Trends Neurosci. 2006, 29, 68-74.